Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devon S Conway

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis and Related Disorders|June 24, 2025
Navigating challenges and embracing opportunities toward achieving equitable multiple sclerosis careAlbert Aboseif, Justin R Abbatemarco, Marisa P McGinley, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2023
The impact of cigarette smoking on cognitive processing speed and brain atrophy in multiple sclerosisEbtesam Alshehri, Jeffrey A Cohen, Daniel Ontaneda, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 22, 2024
Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference ProceedingsLindsay A Ross, Jonathan Lee, Alise K Carlson, et al.
Neurodegenerative Disease Management|January 21, 2025
Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practiceMoein Amin, Tucker Harvey, Dan Michael Pineda, et al.
Annals of Clinical and Translational Neurology|August 29, 2025
Real World Effectiveness and Tolerability of Novel Monoclonal Antibodies and Rituximab for NMOSDZarmina Javed, Mengke Du, Mary Rensel, et al.
Neuroimage|December 5, 2025
Efficient Whole-Brain Quantitative Magnetization Transfer Imaging at 3T Using Segmented EPI Readout with Variable Power Magnetization Transfer Pulses (EP-vpMT)Se-Hong Oh, Ken E Sakaie, Gawon Lee, et al.
Annals of Clinical and Translational Neurology|January 22, 2024
Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disordersSanem P Uysal, Yadi Li, Nicolas R Thompson, et al.
Multiple Sclerosis and Related Disorders|September 11, 2024
A 2-stage model of heterogenous treatment effects for brain atrophy in multiple sclerosis utilizing the MS PATHS research networkCarrie M Hersh, Zhaonan Sun, Devon S Conway, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2025
Longitudinal modeling of upper extremity function in multiple sclerosis: Associations for clinical and sociodemographic factorsFarren Bs Briggs, Jiayue Yang, Karlo Toljan, et al.
Multiple Sclerosis and Related Disorders|November 24, 2019
Technology-enabled comprehensive characterization of multiple sclerosis in clinical practiceLaura E Baldassari, Kunio Nakamura, Brandon P Moss, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis and Related Disorders|June 24, 2025
Navigating challenges and embracing opportunities toward achieving equitable multiple sclerosis careAlbert Aboseif, Justin R Abbatemarco, Marisa P McGinley, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2023
The impact of cigarette smoking on cognitive processing speed and brain atrophy in multiple sclerosisEbtesam Alshehri, Jeffrey A Cohen, Daniel Ontaneda, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 22, 2024
Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference ProceedingsLindsay A Ross, Jonathan Lee, Alise K Carlson, et al.
Neurodegenerative Disease Management|January 21, 2025
Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practiceMoein Amin, Tucker Harvey, Dan Michael Pineda, et al.
Annals of Clinical and Translational Neurology|August 29, 2025
Real World Effectiveness and Tolerability of Novel Monoclonal Antibodies and Rituximab for NMOSDZarmina Javed, Mengke Du, Mary Rensel, et al.
Neuroimage|December 5, 2025
Efficient Whole-Brain Quantitative Magnetization Transfer Imaging at 3T Using Segmented EPI Readout with Variable Power Magnetization Transfer Pulses (EP-vpMT)Se-Hong Oh, Ken E Sakaie, Gawon Lee, et al.
Annals of Clinical and Translational Neurology|January 22, 2024
Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disordersSanem P Uysal, Yadi Li, Nicolas R Thompson, et al.
Multiple Sclerosis and Related Disorders|September 11, 2024
A 2-stage model of heterogenous treatment effects for brain atrophy in multiple sclerosis utilizing the MS PATHS research networkCarrie M Hersh, Zhaonan Sun, Devon S Conway, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2025
Longitudinal modeling of upper extremity function in multiple sclerosis: Associations for clinical and sociodemographic factorsFarren Bs Briggs, Jiayue Yang, Karlo Toljan, et al.
Multiple Sclerosis and Related Disorders|November 24, 2019
Technology-enabled comprehensive characterization of multiple sclerosis in clinical practiceLaura E Baldassari, Kunio Nakamura, Brandon P Moss, et al.
Pageof 6